🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this prospective, single-institution observational study is ...
Status
Completed
Location
UNC Hospital
Start Date
2019-06-20
Trial ID
NCT03885830
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
We want to learn if dasatinib will make triple negative breast cancers smal...
Status
Terminated
Location
Baylor College of Medicine, Lester and Sue Smith Breast Center
Start Date
2008-12
Trial ID
NCT00817531
Treatments Being Tested
This study will enroll CML patients who have failed a first TKI stopping at...
Status
Unknown
Location
Aarhus University Hospital
Start Date
2018-02-01
Trial ID
NCT03573596
Treatments Being Tested
Dasatinib may stop the growth of tumor cells by blocking some of the enzyme...
Status
Completed
Location
Case Western Reserve University
Start Date
2007-05
Trial ID
NCT00474812
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The goal of this clinical research study is to learn if combining Sprycel (...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-06-12
Trial ID
NCT01498445
Treatments Being Tested
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
This is a multicenter, open-label, single arm phase II non-randomized study...
Status
Unknown
Location
Istituto di ematologia "L e A Seragnoli" - Policlinico universitario Sant'Orsola-Malpighi
Start Date
2009-11
Trial ID
NCT00979160
Treatments Being Tested